Clinical Report: Honoring the Legacy of Kristin Page (1974–2024)
Overview
Kristin Page, MD, MHS, MEd, a dedicated pediatric physician, researcher, and mentor, passed away after a months-long illness. She made significant contributions to cancer research, transplant and cellular therapy data operations, and leadership development within the CIBMTR community.
Background
Kristin Page began her career as a high school science teacher before becoming a pediatric physician and researcher focused on cancer. She joined the CIBMTR in 2021 as Senior Scientific Director of Data Operations and Scientific Director of the Acute Leukemia Working Committee. Kristin was known for her expertise in transplant and cellular therapy data, quality, and informatics, and for fostering international collaborations. She was deeply committed to mentorship and leadership development in hematopoietic cell transplantation research.
Data Highlights
Kristin co-developed the Working Committee Training and Leadership (WCTL) program, which has been renamed the CIBMTR Page Scholars in her honor. She played a key role in advancing practice-changing research, including work on measurable residual disease (MRD), and expanded partnerships with international groups such as EBMT and SBTMO.
Key Findings
Kristin transitioned from education to medicine, ultimately specializing in pediatric oncology and transplant research.
She held leadership roles at CIBMTR and Children’s Wisconsin, contributing to data operations and acute leukemia research.
She pioneered the WCTL program to train and mentor emerging leaders in the field.
Kristin fostered international collaborations, enhancing global partnerships in transplant research.
Her mentorship impacted numerous medical students, residents, fellows, and early career investigators.
Colleagues remember her as warm, supportive, and a fearless leader who advanced both science and community.
Clinical Implications
Kristin Page’s work underscores the importance of integrating data quality and informatics in transplant research to drive innovation. Her leadership in training programs highlights the value of mentorship in developing future clinical and research leaders. Continued collaboration across international transplant organizations can enhance research impact and patient care.
Conclusion
Kristin Page’s legacy is marked by her clinical expertise, leadership in data-driven research, and dedication to mentorship. Her contributions will continue to influence the hematopoietic cell transplantation community and inspire future generations.
References
CIBMTR 2024 -- Honoring the Legacy of Kristin Page (1974–2024)
